Restarting or switching therapies common after GLP-1 discontinuation Among patients who discontinued tirzepatide or semaglutide within the first year of treatment, many restarted the original medication or switched to another treatment
At the urging of countless doctors, Long tried calorie-counting, a Mediterranean diet, high-intensity workoutsbut nothing was working, she says
Topical patches have different risk considerations than oral or injected medications
Research showed that weight regain is common after discontinuing semaglutide (a common GLP-1 medication), with people regaining two-thirds of the weight they lost, and improvements in risk factors like blood pressure and HbA1c also reversed
Exercise regularly, as physical activity promotes healthy gut motility
Haredasht FN, Vanhoutte L, Vens C, Pottel H, Viaene L, De Corte W